In this episode:

• How gene therapy works

• The conditions for which gene therapy is currently approved

• The future direction of gene therapy and in particular its potential for treating conditions such as Angelman Syndrome

Expert: Prof David Segal, Biochemistry and Molecular Medicine, Pharmacology

This podcast is intended to be medical advice that is designed for health professionals only. We do not recommend you use this podcast as a substitute for a consult with a qualified health professional.

Foundation for Angelman Syndrome Therapeutics (FAST) is committed to assisting individuals living with Angelman syndrome to realise their full potential and quality of life. Their ultimate goal is to cure Angelman syndrome with a focus on global research, clinician network initiatives, addressing underdiagnosis and contributing to ongoing education of the condition. cureangelman.org.au/

See omnystudio.com/listener for privacy information.